Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial
Clinical trial NCT00934544 · COMPLETED
Trial details
- NCT number
- NCT00934544
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2015-03-04
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.